GDNF poses troubling questions for doctors, drug maker. Toxicity, negative outcome raise doubts.
D000818:Animals; D004341:Drug Evaluation; D064420:Drug-Related Side Effects and Adverse Reactions; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010817:Physician-Patient Relations
D051100:Glial Cell Line-Derived Neurotrophic Factor